# Setmelanotide: new promise for the treatment of hypothalamic obesity?

> PubMed lists PMID 38697183 in The lancet. Diabetes & endocrinology as Journal Article, Comment, with publication-date metadata of 2024-04-30 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-38697183-setmelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2025-05-21
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-38697183-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-38697183-setmelanotide-v1.json
- Content SHA-256: `f6bce41de278c99b188f761039dc09aae812f12efdf5d9e1f18e4db380dd8c79`

## Claims and source pins

### Headline

Setmelanotide: new promise for the treatment of hypothalamic obesity? ([`pubmed-observation-pmid-38697183-2025-05-21-6efa835d669f`](#source-pubmed-observation-pmid-38697183-2025-05-21-6efa835d669f))

### Summary

PubMed lists PMID 38697183 in The lancet. Diabetes & endocrinology as Journal Article, Comment, with publication-date metadata of 2024-04-30 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-38697183-2025-05-21-6efa835d669f`](#source-pubmed-observation-pmid-38697183-2025-05-21-6efa835d669f))

### Paragraph 1

PubMed lists PMID 38697183 in The lancet. Diabetes & endocrinology as Journal Article, Comment, with publication-date metadata of 2024-04-30 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-38697183-2025-05-21-6efa835d669f`](#source-pubmed-observation-pmid-38697183-2025-05-21-6efa835d669f))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-38697183-2025-05-21-6efa835d669f`](#source-pubmed-observation-pmid-38697183-2025-05-21-6efa835d669f))

## Sources

<a id="source-pubmed-observation-pmid-38697183-2025-05-21-6efa835d669f"></a>
- **Setmelanotide: new promise for the treatment of hypothalamic obesity? · retained source version 1:2025-05-21:current:6efa835d669fa42cb097c158573de2ee5fdf145a928c986a5edc7f8e1d36510c** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/38697183/) (`pubmed-observation-pmid-38697183-2025-05-21-6efa835d669f`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Setmelanotide: new promise for the treatment of hypothalamic obesity?" Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-38697183-setmelanotide-v1.json SHA-256: f6bce41de278c99b188f761039dc09aae812f12efdf5d9e1f18e4db380dd8c79.